› $150,000,000 verdict in personal injury case
One year ago this month, the Food and Drug Administration (FDA) issued a black box warning on a common type of laxative known as oral sodium phosphate, or OSP, available both over-the-counter and by prescription. After years of investigation, the FDA finally alerted health care providers and the public of the risk of a serious kidney injury known as acute phosphate nephropathy associated with the use of OSPs.
A randomized clinical study evaluating the safety and efficacy of a new, reduced-volume oral sulfate colon-cleansing preparation for colonoscopy has proven well tolerated and effective in bowel preparation, according to the December 2009 issue of the Journal of the American Academy of Physician Assistants Patient-Oriented Evidence that Matters report.
The U.S. Preventive Services Task Force, a government-appointed, independent panel of doctors and scientists, raised quite a ruckus with its recommendations on the frequency of mammograms and pap smears, bucking the American Cancer Society’s recommendations by suggesting that fewer screenings were necessary for otherwise healthy women. But the task force’s opinions on colonoscopies mirror those of ACS with at least one small exception – limiting colorectal exams for patients 75 years and older.
Let’s face it. There is no comfortable way to prepare for a colonoscopy. You can call it a necessary evil, but colon screenings are necessary for early detection of colorectal cancer for people ages 50 and older, those with a family history, or individuals who are experiencing bothersome symptoms, such as blood in the stool. After all, early detection of precancerous lesions are associated with an up to 90 percent reduction in colon cancer, the country’s second-leading cause of cancer deaths.
Attorney Russell Todd Abney with Beasley Allen Law Firm has filed a lawsuit against C.B. Fleet Company, Inc., on behalf of Mary Little, a resident of Newton County, Georgia, claiming that the plaintiff suffered severe personal injuries as a result of ingesting Fleet’s over-the-counter product known as Fleet Phospho-soda.
Videotaped colonoscopies may result in better physician performance and more accurate outcomes for patients, according to CureToday.com. A study lead by Dr. Douglas Rex with Indiana University Medical Center in Indianapolis found that videotaping such procedures resulted in a change in physician behavior. “Basically the doctors went slower and looked more carefully” when videotaped, Dr. Rex says. The findings were presented this week at the American College of Gastroenterology annual meeting in San Diego, Calif.
The annual meeting of the American College of Gastroenterology in San Diego, Calif., is conjuring up even more good news for consumers, especially those who have to undergo colonoscopies anytime soon. The procedure – which is recommended for those 50 years and older, those with a family history of colon cancer, or those experiencing symptoms of the disease – is getting more accurate, thanks to better techniques and equipment such as a camera that helps detect polyps and other lesions in the colon and the intestines, according to a report on Web MD.
A new study presented at the American College of Gastroenterology’s 74th Annual Scientific Meeting in San Diego, Calif., places new emphasis on the importance of adequate bowel preparation prior to colonoscopies. The news comes as clinicians are evaluating new bowel preparation solutions to replace popular ones that were pulled from the market or given a black box warning by the Food and Drug Administration (FDA).
Forty-eight people who are out of work or without health insurance received free colonoscopy screenings at a Knoxville, Tenn., gastrointestinal clinic over the weekend. Gastrointestinal Associates (GIA) planned the event, called GIA Screening Colonoscopy Day to help those less fortunate and to make everyone aware of the need for colon screenings.
One of the hottest topics in nephrology over the past few years has been the epidemiologic and histopathologic studies that suggest a link between oral sodium phosphate (OSP) colonoscopy preparations and a serious form of kidney injury known as acute phosphate nephrology, according to The Renal Fellow Network.
As more cases of the condition were reported to the Food and Drug Administration (FDA), the agency last December issued a black box warning on prescription brands of OSP, such as Visicol and Osmo Prep. C.B. Fleet, makers of over-the-counter OSPs, also pulled their products from store shelves. While the Fleet products were deemed safe when taken in low doses as a laxative, Fleet had recommended doctors to tell their patients to use the over-the-counter OSPs in higher doses to prep the bowel prior to colonoscopies.
